drugset / Trial / NCT00624910
Efficacy and Safety of a Collagen Bupivacaine Implant in Women Following Abdominal Hysterectomy
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether the CollaRx Bupivacaine implant is safe and effective in reducing the amount of narcotic pain medication needed to control pain during the first 24 hours after abdominal hysterectomy surgery.
Timeline
- Start
- 2007-12-27
- Primary completion
- 2008-09-05
- Completion
- 2008-09-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 150 mg | Other |
Indications
No indication recorded.